Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Swapping roles or swapping desks? When experienced practitioners become students on placement

field instruction

Crisp BR, Maidment J.
GSID: 2ock4paIoloJ
BR Crisp, J Maidment - Learning in Health and Social Care, 2009 - Wiley Online Library

The social work education literature on the preparation of students for their first practice learning placement, and the support needs of such students once in placement, tend to …

Cite
Crisp, B. R., & Maidment, J. (2009). Swapping roles or swapping desks? When experienced practitioners become students on placement. Learning in Health and Social Care, 8(3), 165-174.
Crisp, Beth R., and Jane Maidment. "Swapping roles or swapping desks? When experienced practitioners become students on placement." Learning in Health and Social Care 8.3 (2009): 165-174.
Copy Download .nbib Format: MLA
Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care - What are the Positive and Negative Effects and Who Should Deliver It?.

Current Alzheimer research

Smith T, Cross J, Poland F, Clay F, Brookes A, Maidment I, Penhale B, Laidlaw K, Fox C.
PMID: 28891442
Curr Alzheimer Res. 2018;15(1):5-17. doi: 10.2174/1567205014666170908094931.

BACKGROUND: Primary care services frequently provide the initial contact between people with dementia and health service providers. Early diagnosis and screening programmes have been suggested as a possible strategy to improve the identification of such individuals and treatment and...

Cite
Smith T, Cross J, Poland F, et al. Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care - What are the Positive and Negative Effects and Who Should Deliver It?. Curr Alzheimer Res. 2018;15(1):5-17doi: 10.2174/1567205014666170908094931.
Smith, T., Cross, J., Poland, F., Clay, F., Brookes, A., Maidment, I., Penhale, B., Laidlaw, K., & Fox, C. (2018). Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care - What are the Positive and Negative Effects and Who Should Deliver It?. Current Alzheimer research, 15(1), 5-17. https://doi.org/10.2174/1567205014666170908094931
Smith, Toby, et al. "Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care - What are the Positive and Negative Effects and Who Should Deliver It?." Current Alzheimer research vol. 15,1 (2018): 5-17. doi: https://doi.org/10.2174/1567205014666170908094931
Smith T, Cross J, Poland F, Clay F, Brookes A, Maidment I, Penhale B, Laidlaw K, Fox C. Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care - What are the Positive and Negative Effects and Who Should Deliver It?. Curr Alzheimer Res. 2018;15(1):5-17. doi: 10.2174/1567205014666170908094931. PMID: 28891442.
Copy Download .nbib Format: NLM
Medication error in mental health: implications for primary care.

Mental health in family medicine

Maidment ID, Parmentier H.
PMID: 22477911
Ment Health Fam Med. 2009 Dec;6(4):203-7.

Medication errors are associated with significant morbidity and people with mental health problems may be particularly susceptible to medication errors due to various factors. Primary care has a key role in improving medication safety in this vulnerable population. The...

Cite
Maidment ID, Parmentier H. Medication error in mental health: implications for primary care. Ment Health Fam Med. 2009;6(4):203-7
Maidment, I. D., & Parmentier, H. (2009). Medication error in mental health: implications for primary care. Mental health in family medicine, 6(4), 203-7.
Maidment, Ian D, and Parmentier, Henk. "Medication error in mental health: implications for primary care." Mental health in family medicine vol. 6,4 (2009): 203-7.
Maidment ID, Parmentier H. Medication error in mental health: implications for primary care. Ment Health Fam Med. 2009 Dec;6(4):203-7. PMID: 22477911; PMCID: PMC2873876.
Copy Download .nbib Format: NLM
Alcohol-Paired Contextual Cues Produce an Immediate and Selective Loss of Goal-directed Action in Rats.

Frontiers in integrative neuroscience

Ostlund SB, Maidment NT, Balleine BW.
PMID: 20725634
Front Integr Neurosci. 2010 Jul 19;4. doi: 10.3389/fnint.2010.00019. eCollection 2010.

We assessed whether the presence of contextual cues paired with alcohol would disrupt rats' capacity to express appropriate goal-directed action control. Rats were first given differential context conditioning such that one set of contextual cues was paired with the...

Cite
Ostlund SB, Maidment NT, Balleine BW. Alcohol-Paired Contextual Cues Produce an Immediate and Selective Loss of Goal-directed Action in Rats. Front Integr Neurosci. 2010;4doi: 10.3389/fnint.2010.00019.
Ostlund, S. B., Maidment, N. T., & Balleine, B. W. (2010). Alcohol-Paired Contextual Cues Produce an Immediate and Selective Loss of Goal-directed Action in Rats. Frontiers in integrative neuroscience, 4. https://doi.org/10.3389/fnint.2010.00019
Ostlund, Sean B, et al. "Alcohol-Paired Contextual Cues Produce an Immediate and Selective Loss of Goal-directed Action in Rats." Frontiers in integrative neuroscience vol. 4 (2010). doi: https://doi.org/10.3389/fnint.2010.00019
Ostlund SB, Maidment NT, Balleine BW. Alcohol-Paired Contextual Cues Produce an Immediate and Selective Loss of Goal-directed Action in Rats. Front Integr Neurosci. 2010 Jul 19;4. doi: 10.3389/fnint.2010.00019. eCollection 2010. PMID: 20725634; PMCID: PMC2917216.
Copy Download .nbib Format: NLM
Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis.

Translational oncology

Mattiucci GC, Morganti AG, Cellini F, Buwenge M, Casadei R, Farioli A, Alfieri S, Arcelli A, Bertini F, Calvo FA, Cammelli S, Fuccio L, Giaccherini L, Guido A, Herman JM, Macchia G, Maidment BW, Miller RC, Minni F, Regine WF, Reni M, Partelli S, Falconi M, Valentini V.
PMID: 30237099
Transl Oncol. 2019 Jan;12(1):1-7. doi: 10.1016/j.tranon.2018.08.017. Epub 2018 Sep 17.

BACKGROUND: Presurgical carbohydrate antigen 19-9 (CA19-9) level predicts overall survival (OS) in resected pancreatic adenocarcinoma (PaC). The aim of this pooled analysis was to evaluate if presurgical CA19-9 level can also predict local control (LC) and distant metastasis-free survival...

Cite
Mattiucci GC, Morganti AG, Cellini F, et al. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Transl Oncol. 2018;12(1):1-7doi: 10.1016/j.tranon.2018.08.017.
Mattiucci, G. C., Morganti, A. G., Cellini, F., Buwenge, M., Casadei, R., Farioli, A., Alfieri, S., Arcelli, A., Bertini, F., Calvo, F. A., Cammelli, S., Fuccio, L., Giaccherini, L., Guido, A., Herman, J. M., Macchia, G., Maidment, B. W., Miller, R. C., Minni, F., Regine, W. F., Reni, M., Partelli, S., Falconi, M., & Valentini, V. (2019). Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Translational oncology, 12(1), 1-7. https://doi.org/10.1016/j.tranon.2018.08.017
Mattiucci, Gian Carlo, et al. "Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis." Translational oncology vol. 12,1 (2019): 1-7. doi: https://doi.org/10.1016/j.tranon.2018.08.017
Mattiucci GC, Morganti AG, Cellini F, Buwenge M, Casadei R, Farioli A, Alfieri S, Arcelli A, Bertini F, Calvo FA, Cammelli S, Fuccio L, Giaccherini L, Guido A, Herman JM, Macchia G, Maidment BW, Miller RC, Minni F, Regine WF, Reni M, Partelli S, Falconi M, Valentini V. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Transl Oncol. 2019 Jan;12(1):1-7. doi: 10.1016/j.tranon.2018.08.017. Epub 2018 Sep 17. PMID: 30237099; PMCID: PMC6143718.
Copy Download .nbib Format: NLM
Pearls.

The Physician and sportsmedicine

Scalone J, Miller C, Laskowski E, Maidment J.
PMID: 29275686
Phys Sportsmed. 1995 Mar;23(3):18. doi: 10.1080/00913847.1995.11947755.

No abstract available.

Cite
Scalone J, Miller C, Laskowski E, et al. Pearls. Phys Sportsmed. 1995;23(3):18doi: 10.1080/00913847.1995.11947755.
Scalone, J., Miller, C., Laskowski, E., & Maidment, J. (1995). Pearls. The Physician and sportsmedicine, 23(3), 18. https://doi.org/10.1080/00913847.1995.11947755
Scalone, James, et al. "Pearls." The Physician and sportsmedicine vol. 23,3 (1995): 18. doi: https://doi.org/10.1080/00913847.1995.11947755
Scalone J, Miller C, Laskowski E, Maidment J. Pearls. Phys Sportsmed. 1995 Mar;23(3):18. doi: 10.1080/00913847.1995.11947755. PMID: 29275686.
Copy Download .nbib Format: NLM
Molecular fingerprint-region spectroscopy from 5 to 12  μm using an orientation-patterned gallium phosphide optical parametric oscillator.

Optics letters

Maidment L, Schunemann PG, Reid DT.
PMID: 27628372
Opt Lett. 2016 Sep 15;41(18):4261-4. doi: 10.1364/OL.41.004261.

We report a femtosecond optical parametric oscillator (OPO) based on the new semiconductor gain material orientation-patterned gallium phosphide (OP-GaP), which enables the production of high-repetition-rate femtosecond pulses spanning 5-12 μm with average powers in the few to tens of...

Cite
Maidment L, Schunemann PG, Reid DT. Molecular fingerprint-region spectroscopy from 5 to 12  μm using an orientation-patterned gallium phosphide optical parametric oscillator. Opt Lett. 2016;41(18):4261-4doi: 10.1364/OL.41.004261.
Maidment, L., Schunemann, P. G., & Reid, D. T. (2016). Molecular fingerprint-region spectroscopy from 5 to 12  μm using an orientation-patterned gallium phosphide optical parametric oscillator. Optics letters, 41(18), 4261-4. https://doi.org/10.1364/OL.41.004261
Maidment, Luke, et al. "Molecular fingerprint-region spectroscopy from 5 to 12  μm using an orientation-patterned gallium phosphide optical parametric oscillator." Optics letters vol. 41,18 (2016): 4261-4. doi: https://doi.org/10.1364/OL.41.004261
Maidment L, Schunemann PG, Reid DT. Molecular fingerprint-region spectroscopy from 5 to 12  μm using an orientation-patterned gallium phosphide optical parametric oscillator. Opt Lett. 2016 Sep 15;41(18):4261-4. doi: 10.1364/OL.41.004261. PMID: 27628372.
Copy Download .nbib Format: NLM
Family carers' experiences of managing older relative's medications: Insights from the MEMORABLE study.

Patient education and counseling

Lawson S, Mullan J, Wong G, Zaman H, Booth A, Watson A, Maidment I.
PMID: 35016779
Patient Educ Couns. 2021 Dec 31; doi: 10.1016/j.pec.2021.12.017. Epub 2021 Dec 31.

OBJECTIVE: To explore the burdens experienced by family carers who support older relatives to manage their medications at home.METHODS: This study, based on a larger UK medication management study: MEdication Management in Older people: Realist Approaches Based on Literature...

Cite
Lawson S, Mullan J, Wong G, et al. Family carers' experiences of managing older relative's medications: Insights from the MEMORABLE study. Patient Educ Couns. 2021;doi: 10.1016/j.pec.2021.12.017.
Lawson, S., Mullan, J., Wong, G., Zaman, H., Booth, A., Watson, A., & Maidment, I. (2021). Family carers' experiences of managing older relative's medications: Insights from the MEMORABLE study. Patient education and counseling, . https://doi.org/10.1016/j.pec.2021.12.017
Lawson, Sally, et al. "Family carers' experiences of managing older relative's medications: Insights from the MEMORABLE study." Patient education and counseling vol. (2021). doi: https://doi.org/10.1016/j.pec.2021.12.017
Lawson S, Mullan J, Wong G, Zaman H, Booth A, Watson A, Maidment I. Family carers' experiences of managing older relative's medications: Insights from the MEMORABLE study. Patient Educ Couns. 2021 Dec 31; doi: 10.1016/j.pec.2021.12.017. Epub 2021 Dec 31. PMID: 35016779.
Copy Download .nbib Format: NLM
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).

Clinical lung cancer

Yu HA, Goldberg SB, Le X, Piotrowska Z, Goldman JW, De Langen AJ, Okamoto I, Cho BC, Smith P, Mensi I, Ambrose H, Kraljevic S, Maidment J, Chmielecki J, Li-Sucholeiki X, Doughton G, Patel G, Jewsbury P, Szekeres P, Riess JW.
PMID: 34389237
Clin Lung Cancer. 2021 Nov;22(6):601-606. doi: 10.1016/j.cllc.2021.06.006. Epub 2021 Jun 25.

INTRODUCTION: Osimertinib, a third-generation, irreversible, epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), selectively inhibits both EGFR-TKI sensitizing (EGFRm) and EGFR T790M resistance mutations and has demonstrated efficacy in non-small cell lung cancer (NSCLC) CNS metastases. Most patients with...

Cite
Yu HA, Goldberg SB, Le X, et al. Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD). Clin Lung Cancer. 2021;22(6):601-606doi: 10.1016/j.cllc.2021.06.006.
Yu, H. A., Goldberg, S. B., Le, X., Piotrowska, Z., Goldman, J. W., De Langen, A. J., Okamoto, I., Cho, B. C., Smith, P., Mensi, I., Ambrose, H., Kraljevic, S., Maidment, J., Chmielecki, J., Li-Sucholeiki, X., Doughton, G., Patel, G., Jewsbury, P., Szekeres, P., & Riess, J. W. (2021). Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD). Clinical lung cancer, 22(6), 601-606. https://doi.org/10.1016/j.cllc.2021.06.006
Yu, Helena A, et al. "Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)." Clinical lung cancer vol. 22,6 (2021): 601-606. doi: https://doi.org/10.1016/j.cllc.2021.06.006
Yu HA, Goldberg SB, Le X, Piotrowska Z, Goldman JW, De Langen AJ, Okamoto I, Cho BC, Smith P, Mensi I, Ambrose H, Kraljevic S, Maidment J, Chmielecki J, Li-Sucholeiki X, Doughton G, Patel G, Jewsbury P, Szekeres P, Riess JW. Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD). Clin Lung Cancer. 2021 Nov;22(6):601-606. doi: 10.1016/j.cllc.2021.06.006. Epub 2021 Jun 25. PMID: 34389237.
Copy Download .nbib Format: NLM
Evaluation of Convolutional Neural Networks for Search in 1/f .

Proceedings of SPIE--the International Society for Optical Engineering

Jonnalagadda A, Lago MA, Barufaldi B, Bakic PR, Abbey CK, Maidment AD, Eckstein MP.
PMID: 32435081
Proc SPIE Int Soc Opt Eng. 2020 Feb;11316. doi: 10.1117/12.2549362. Epub 2020 Mar 16.

With the advent of powerful convolutional neural networks (CNNs), recent studies have extended early applications of neural networks to imaging tasks thus making CNNs a potential new tool for assessing medical image quality. Here, we compare a CNN to...

Cite
Jonnalagadda A, Lago MA, Barufaldi B, et al. Evaluation of Convolutional Neural Networks for Search in 1/f . Proc SPIE Int Soc Opt Eng. 2020;11316doi: 10.1117/12.2549362.
Jonnalagadda, A., Lago, M. A., Barufaldi, B., Bakic, P. R., Abbey, C. K., Maidment, A. D., & Eckstein, M. P. (2020). Evaluation of Convolutional Neural Networks for Search in 1/f . Proceedings of SPIE--the International Society for Optical Engineering, 11316. https://doi.org/10.1117/12.2549362
Jonnalagadda, Aditya, et al. "Evaluation of Convolutional Neural Networks for Search in 1/f ." Proceedings of SPIE--the International Society for Optical Engineering vol. 11316 (2020). doi: https://doi.org/10.1117/12.2549362
Jonnalagadda A, Lago MA, Barufaldi B, Bakic PR, Abbey CK, Maidment AD, Eckstein MP. Evaluation of Convolutional Neural Networks for Search in 1/f . Proc SPIE Int Soc Opt Eng. 2020 Feb;11316. doi: 10.1117/12.2549362. Epub 2020 Mar 16. PMID: 32435081; PMCID: PMC7237823.
Copy Download .nbib Format: NLM
The impact of presentation modality on cognitive test performance for adults with hearing loss.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Goodwin MV, Hogervorst E, Maidment DW.
PMID: 34971091
Alzheimers Dement. 2021 Dec;17:e058571. doi: 10.1002/alz.058571.

BACKGROUND: There is a growing body of evidence demonstrating hearing loss in middle-aged and older adults is independently associated with an increased risk of developing cognitive-decline and dementia. Verbal memory is one of the most common functions to decline...

Cite
Goodwin MV, Hogervorst E, Maidment DW. The impact of presentation modality on cognitive test performance for adults with hearing loss. Alzheimers Dement. 2021;17:e058571doi: 10.1002/alz.058571.
Goodwin, M. V., Hogervorst, E., & Maidment, D. W. (2021). The impact of presentation modality on cognitive test performance for adults with hearing loss. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17e058571. https://doi.org/10.1002/alz.058571
Goodwin, Maria V, et al. "The impact of presentation modality on cognitive test performance for adults with hearing loss." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 17 (2021): e058571. doi: https://doi.org/10.1002/alz.058571
Goodwin MV, Hogervorst E, Maidment DW. The impact of presentation modality on cognitive test performance for adults with hearing loss. Alzheimers Dement. 2021 Dec;17:e058571. doi: 10.1002/alz.058571. PMID: 34971091.
Copy Download .nbib Format: NLM
Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.

The Journal of neuroscience : the official journal of the Society for Neuroscience

McGregor R, Wu MF, Holmes B, Lam HA, Maidment NT, Gera J, Yamanaka A, Siegel JM.
PMID: 34853083
J Neurosci. 2022 Jan 12;42(2):255-263. doi: 10.1523/JNEUROSCI.1557-21.2021. Epub 2021 Dec 01.

We previously found that human heroin addicts and mice chronically exposed to morphine exhibit a significant increase in the number of detected hypocretin/orexin (Hcrt)-producing neurons. However, it remains unknown how this increase affects target areas of the hypocretin system...

Cite
McGregor R, Wu MF, Holmes B, et al. Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome. J Neurosci. 2021;42(2):255-263doi: 10.1523/JNEUROSCI.1557-21.2021.
McGregor, R., Wu, M. F., Holmes, B., Lam, H. A., Maidment, N. T., Gera, J., Yamanaka, A., & Siegel, J. M. (2022). Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome. The Journal of neuroscience : the official journal of the Society for Neuroscience, 42(2), 255-263. https://doi.org/10.1523/JNEUROSCI.1557-21.2021
McGregor, Ronald, et al. "Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome." The Journal of neuroscience : the official journal of the Society for Neuroscience vol. 42,2 (2022): 255-263. doi: https://doi.org/10.1523/JNEUROSCI.1557-21.2021
McGregor R, Wu MF, Holmes B, Lam HA, Maidment NT, Gera J, Yamanaka A, Siegel JM. Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome. J Neurosci. 2022 Jan 12;42(2):255-263. doi: 10.1523/JNEUROSCI.1557-21.2021. Epub 2021 Dec 01. PMID: 34853083.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries